LabCorp (LH -0.2%) announces testing method that can simultaneously detect COVID-19, influenza A / B, and respiratory syncytial virus (“RSV”).
The single test will help doctors diagnose patients and make decisions about treatment options; available to patients through doctors, hospitals, and other authorized healthcare providers nationwide.
LabCorp has also submitted an application to the U.S. Food and Drug Administration to offer the combined test through its Pixel by LabCorp™ at-home test collection kit, which would offer added convenience and accessibility.
https://seekingalpha.com/news/3612174-labcorp-launches-combined-test-for-covidminus-19-flu-and-rsv
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.